opioid peptide activity

Definition

Target type: molecularfunction

Naturally occurring peptide that is an opioid (any non-alkaloid having an opiate-like effect that can be reversed by naloxone or other recognized morphine antagonist). These include Leu- and Met-enkephalin, dynorphin and neoendorphin, alpha, beta, gamma and delta endorphins formed from beta-lipotropin, various pronase-resistant peptides such as beta casamorphin, and other peptides whose opiate-like action seems to be indirect. [ISBN:0198506732]

Opioid peptides are a diverse group of signaling molecules that exert their effects by binding to and activating opioid receptors, which are G protein-coupled receptors located in the central nervous system (CNS) and peripheral tissues. These receptors are classified into three main subtypes: mu (MOR), delta (DOR), and kappa (KOR), each with distinct pharmacological properties and downstream signaling pathways. Opioid peptides mediate a wide range of biological functions, including pain modulation, reward and reinforcement, stress response, mood regulation, and gastrointestinal motility.

Upon binding to opioid receptors, opioid peptides trigger a cascade of intracellular events that ultimately lead to the activation of various signaling pathways. The primary mechanism involves the activation of G proteins, which are heterotrimeric complexes composed of alpha, beta, and gamma subunits. Upon receptor activation, the alpha subunit dissociates from the beta-gamma complex and interacts with downstream effectors, including adenylyl cyclase, phospholipase C, and ion channels.

Inhibition of adenylyl cyclase activity is a key downstream effect of opioid receptor activation, leading to a reduction in the production of cyclic adenosine monophosphate (cAMP). cAMP is a second messenger molecule involved in various cellular processes, including gene transcription, cell growth, and neurotransmitter release. By suppressing cAMP levels, opioid peptides modulate neuronal activity and contribute to their analgesic, anxiolytic, and mood-altering effects.

Activation of phospholipase C, another downstream effector of opioid receptor signaling, results in the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the release of calcium ions from intracellular stores, while DAG activates protein kinase C (PKC), a family of serine/threonine kinases. These signaling pathways contribute to the modulation of cellular processes, including neurotransmitter release, synaptic plasticity, and cell proliferation.

Opioid peptides also exert their effects by directly interacting with ion channels. For example, opioid receptor activation can lead to the opening of potassium channels, resulting in membrane hyperpolarization and decreased neuronal excitability. This mechanism contributes to the analgesic and sedative effects of opioids.

In addition to their direct effects on cellular signaling pathways, opioid peptides can also modulate gene expression through the activation of transcription factors. For example, opioid receptor activation has been shown to induce the expression of certain genes involved in pain perception, stress response, and reward pathways.

The precise molecular mechanisms underlying the diverse effects of opioid peptides are complex and not fully understood. However, it is clear that these signaling molecules play critical roles in a wide range of physiological processes, including pain modulation, reward and addiction, stress response, mood regulation, and gastrointestinal motility. Their therapeutic potential in the treatment of various diseases, including chronic pain, anxiety, and depression, is actively being explored.'
"

Proteins (1)

Compounds (1)